Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 28, 2013
Pharmaceutical contract manufacturer, Sanico NV, has increased tablet inspection at its Turnhout facility in Belgium to 100% with the installation of four INSIGHT PH metal detectors from Lock Inspection Systems. The investment is part of the company...
read more
Wednesday, December 07, 2016
Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
read more
Saneca Pharma has renewed an agreement with Pharmascience for the manufacture and supply of prescription medicines in tablet form.
read more
Thursday, September 22, 2016
Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has added senior talent to its team to position the company for its next phase of growth.
read more
Wednesday, November 09, 2016
Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled release pellets for one of its products.
read more
Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.
read more
Friday, February 16, 2018
CDMO Saneca Pharma has announced the appointment of its new CEO, Richard Král.
read more
Sandoz announced today that Dr. Mark McCamish, Head of Global Biopharmaceutical Development, will present on behalf of the Novartis Group of companies (Novartis) at the May 11 Food and Drug Administration (FDA) public hearing on draft guidances ...
read more
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
read more
Wednesday, December 19, 2018
Sandoz has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.
read more
Sandoz has completed its USD 1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.
read more
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Thursday, October 08, 2020
A partnership between Sandia National Laboratories and BioBright to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to ...
read more
SanBio Group and Hitachi Chemical jointly announced that they will manufacture SB623, a proprietary regenerative medicine product under development by SanBio.
read more
Monday, September 17, 2018
Samumed has entered an exclusive license agreement with United Therapeutics for North American rights to Samumed's SM04646, being developed for the treatment of idiopathic pulmonary fibrosis.
read more